News

Independent Medical Alliance Unveils New Journal Volume for Healthcare

Independent Medical Alliance Unveils New Journal Volume for Healthcare

Independent Medical Alliance Launches New Journal Edition

New Volume Expands Global Reach of Independent Science as Public Demand Grows for Transparency in Health Research

Today, the Independent Medical Alliance (IMA) proudly announced the launch of Volume 1, Issue No. 4 of the Journal of Independent Medicine, showcasing the success of its quarterly publication this year. The journal serves as an essential scientific resource for physicians, researchers, and patients interested in accessing unbiased, evidence-based research, free from corporate influences.

Dr. Joseph Varon, the Editor-in-Chief of the Journal of Independent Medicine and President of IMA, remarked, "As federal agencies emphasize the importance of transparency and independent science, our journal is addressing the void left by traditional institutions that may be compromised. We are committed to publishing thorough, peer-reviewed studies that challenge established norms, foster open conversation, and promote a shift from captured science to independent medicine."

The Journal of Independent Medicine stands out among peer-reviewed scientific publications due to its commitment to covering sensitive and underreported subjects. Topics like vaccine safety, chronic disease prevention, and medical ethics are examined rigorously. Each issue is not only peer-reviewed but also maintains a policy against pharmaceutical sponsorship, ensuring an independent and accessible platform for both clinicians and the public.

Looking forward into the next year, the Journal of Independent Medicine is set to double its output, offering six issues each year. Among these, two special editions will focus on pressing healthcare issues that are often overlooked:

Upcoming Special Editions

  • Treating Post-Vaccine Complications
  • Repurposed Drugs and Nutraceuticals in the Chronic Disease Epidemic

Dr. Varon stated, "These forthcoming editions embody our goal to equip healthcare providers and patients with the necessary information for informed decision-making and comprehensive care. By addressing these neglected topics, we aim to rebuild trust within the medical community and lay the groundwork for meaningful reform."

In this latest volume, notable articles include:

Featured Articles in Volume 1, Issue No. 4

Review Articles

  • Considering the Safety of COVID-19 mRNA Vaccines in Patients with Aneuploidy by Martin J. McCaffrey examines the interaction of genetic anomalies with mRNA vaccine mechanisms, raising crucial questions regarding patient-specific safety.
  • Preventing Cancer: The ROOT Protocols by Paul Marik & Justus Hope investigates nutraceutical and drug strategies aimed at reducing cancer risk through optimized metabolic health and lifestyle changes.
  • A Holistic Approach to Improve Metabolic Health: A Practical Review by Pei Harris & Joseph Varon presents a roadmap for reversing metabolic syndrome through diet, lifestyle adjustments, and integrative treatments.
  • Beyond the Dead Donor Rule: Medicine, Ethics, and the Future of Organ Procurement by Joseph Varon & Matthew Halma offers a historical and ethical perspective on organ donation practices and their contemporary impacts on healthcare.
  • Vaccine-Induced Viral Reactivation and Autism Spectrum Disorder by Matthew Cormier explores potential connections between post-vaccination viral reactivation and neurodevelopmental disorders.
  • A Non-Isolated Call for Rigor: The History of the 'Anti-Vaccination Movement' by Matthew Halma & Joseph Varon analyzes the evolution and scientific standards required for credible advocacy in medical freedom.
  • Palliative Care in Iraq: A Health Systems Imperative for Equity by Santiago Herrero discusses urgent needs for global health equity in end-of-life care in conflict zones.

Original Articles

  • Metacritique of Influential Studies Purporting COVID-19 Vaccine Successes: Part 3 by Raphael Lataster completes a detailed critique of the methodologies that underlie efficacy claims surrounding vaccines.

Case Reports

  • Cavernous Dural Arteriovenous Fistula Following COVID-19 mRNA Vaccination by Dean Patterson et al. reviews a case highlighting possible neurological complications and diagnostic hurdles.

Letter to the Editor

  • A Dramatic Increase in the Rate of Disability in the American Civilian Labor Force by Hal Switkay statistically analyzes the rising trend in disability rates, calling for public health scrutiny.

This edition, along with past issues, is accessible without charge at www.JIndepMed.org.

About the Journal of Independent Medicine

The Journal of Independent Medicine, published quarterly by the Independent Medical Alliance™, functions as a refuge for scientific integrity. It prioritizes independent research free from pharmaceutical influence, focusing on the needs of patients and upholding rigorous standards over ideological bias. The journal features contributions from an international editorial board representing 43 experts across 17 countries and multiple specialties.

About the Independent Medical Alliance (IMA)

The Independent Medical Alliance™ is a nonprofit organization that unites healthcare professionals in their pursuit to enhance trust and transparency in medical care. Its mission, driven by the principles of Honest Medicine™, stresses patient welfare over profit, emphasizing proactive wellness and preventive measures. By promoting evidence-based practices and informed consent, IMA advocates for systemic improvements in healthcare. Its advocacy arm, IMA Action, actively engages in public health discussions at various levels, amplifying grassroots efforts for transparency and accountability.

Frequently Asked Questions

What is the purpose of the Journal of Independent Medicine?

The journal aims to provide a platform for publishing unbiased research and articles, emphasizing independent science free from corporate funding.

How often is the Journal published?

The journal is set to increase its frequency to six issues per year, including special editions on critical healthcare topics.

Who contributes to the journal?

The journal features contributions from a diverse editorial board comprising 43 experts from various specialties across 17 countries.

What types of topics are covered?

It covers a range of important health issues, including vaccine safety, chronic disease management, and medical ethics, with in-depth peer-reviewed articles.

How can I access past issues of the journal?

All past and current issues are available for free at www.JIndepMed.org.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

F.N.B. Q3 2026 Earnings: Solid Growth Continues

Updated Category News Views 5

F.N.B. Stays the Course with Strong Q3 2026 Ever heard the phrase “slow and steady wins the race?” That seems to be the mantra over at F.N.B. Corporation (NYSE: FNB) as they roll out their Q3 2026 earnings. Now, they aren't breaking any land speed records, but what they are doing is consistently stepping up their game, quarter by quarter, like clockwork. Drilling Down...

Continue Reading
Ryan Stills: Vegan Powerlifter Defies Odds, Wins Sixth World Title

Updated Category News Views 11

Ryan Stills: A Comeback Story for the Ages Ryan Stills isn't just lifting weights; he's lifting the entire perception of what's possible after a heavy surgical setback. We're talking about a guy who stared down a hemi-shoulder replacement—a career ender for many—and came out the other side with a whole new set of gold medals. Two years ago, some might have written him...

Continue Reading
Netcapital Faces Securities Fraud Claims: Key Investor Notes

Updated Category News Views 5

Netcapital Under Fire: The Suit Unfolds You ever see a stock go through such highs and lows that you wish you had popcorn on standby? Well, that's where Netcapital Inc. (NASDAQ: NCPL) is sitting right now, in the midst of a class action lawsuit that's got investors' heads spinning. The accusations are serious: false and misleading statements about revenues that seem to...

Continue Reading
Alaska LNG Project Boosted by Strategic Positioning

Updated Category News Views 9

Alaska LNG: Right Place, Right Time Someone bring out the confetti, because Paul Sullivan, Co-Chairman of Gastech, is celebrating Alaska LNG like it's 1999. And for good reason. If Alaska ever played its cards right, now's the moment according to the industry veteran. After Gastech 2026 wrapped its events in Bangkok last month, Sullivan laid out why the stars are aligning...

Continue Reading
Spooky Suds: House of Horror Meets El Car Wash

Updated Category News Views 12

A Haunted Wash Awaits Miami Drivers Picture this: you're cruising down West Flagler on a regular Wednesday evening, but tonight, you're not just rolling in for a rinse. Nope, this Wednesday night, the wash tunnel at El Car Wash gets downright spooky. It's getting a haunted house makeover with scare actors from the House of Horror. When a Car Wash Becomes a Haunted...

Continue Reading
Veteran Team Fuels Misunderstood Brands' Bold Expansion

Updated Category News Views 8

Adding Heavyweights to Catalyze Growth Imagine you're Misunderstood Brands, prepping your artillery before charging into the battleground of national chains. What do you do? You double down strategically by rallying the best industry minds around. Announced on October 15, 2026, this company's concocted a dream team of beverage veterans as they steer their products—like...

Continue Reading
BETR's Legal Clash: Investor Action Deadline Nears

Updated Category News Views 8

BETR's Woes in the Legal Spotlight Investors who’ve been keeping an eye on Better Home & Finance Holding Company—trading as BETR on NASDAQ—might wanna pinch themselves. Not every day do you see a class action lawsuit waiting on the horizon like this one. The folks over at Schall, Brown & Schwartz LLP, those wily veterans in shareholder rights litigation, are...

Continue Reading
Navigating the Nitty-Gritty of Cabin Rental Management

Updated Category News Views 9

The Real Elbow Grease Behind Cabin Management Ever imagined what it’d take to keep a vacation rental cabin running like a tight ship? Well, Nathan Fitts breaks it down real clear-like. The guy's seen it all in Blue Ridge, Georgia, which isn't just about scenic views—there's serious business brewing behind that cabin charm. More Than Just Fluffing Pillows Turns out,...

Continue Reading
Standex's New Financial Lead: Stoddard Takes Helm

Updated Category News Views 9

New Financial Captain Aboard Standex's Ship Alright, here's something that'll have investors nodding along with interest: Standex International has just named Samantha L. Stoddard as their incoming Chief Financial Officer and Treasurer, effective December 1, 2026. Now, Standex isn't some scrappy upstart. We're talking about a veteran manufacturer intricately working...

Continue Reading
CMS Proposal Sparks Controversy in Lab Certification

Updated Category News Views 8

A New Contender in the Battle Over Lab Standards Here's what’s heating up in the realm of clinical laboratories: A proposed shift by the Centers for Medicare & Medicaid Services (CMS) that reeks of cutting corners, if you ask the folks at the Association for Diagnostics & Laboratory Medicine (ADLM). They’re banging the drums against CMS's idea to nix the board...

Continue Reading

Top 5 Most Recently Viewed Articles

Watsco Increases Annual Dividend by 11% Reflecting Growth

Updated Category News Views 102

Watsco Announces Dividend Increase Watsco, Inc. has recently made headlines by announcing an impressive 11% increase in its annual dividend, raising it to $12.00 per share. This increase will be applicable to all outstanding shares of its Common and Class B common stock. The decision indicates a positive outlook and will take effect with the upcoming quarterly dividend...

Continue Reading
JumpCloud Takes the Lead in IT Management with G2 Recognition

Updated Category News Views 67

JumpCloud Excels with a Record Number of G2 Awards In a remarkable achievement, JumpCloud Inc. has emerged as a leader in 119 G2 Winter 2024 Grid Reports. This accolade comes after the company received over 2,950 reviews from G2 users, highlighting its strength in delivering exceptional IT management solutions. The G2 Grid Reports evaluate products based on user feedback...

Continue Reading
Brooke Rollins and Controversies in Agriculture Policies

Updated Category News Views 693

Brooke Rollins: A New Face at the USDA President Donald Trump's choice to lead the Agriculture Department, Brooke Rollins (NYSE: ROL), has drawn significant attention due to her leadership of an organization that has consistently opposed ethanol mandates and farm subsidies. These are crucial areas she may influence if confirmed, raising eyebrows among lawmakers and...

Continue Reading
Traws Pharma's Breakthrough in H5N1 Treatment Development

Updated Category News Views 113

Innovation in Treating H5N1 Bird Flu by Traws Pharma Traws Pharma, Inc. (NASDAQ: TRAW), a clinical-stage biopharmaceutical company known for developing therapies for respiratory viral diseases, has recently made notable advancements with its investigational treatment, tivoxavir marboxil. This one-dose therapy is being developed specifically for the treatment and...

Continue Reading
Standard Motor Products Unveils Enhanced Corporate Website for Investors

Updated Category News Views 78

Standard Motor Products Launches New Corporate Website Standard Motor Products, Inc. (NYSE: SMP) is excited to unveil its newly designed corporate website. This launch aims to provide enhanced resources for investors and streamline access to vital company information. Collaborating closely with Scandia, a top digital and web development agency, the site has undergone...

Continue Reading